Semax as a Universal Drug for Therapy and Research
- Autores: Koroleva S.V.1, Myasoedov N.F.1
-
Afiliações:
- Institute of Molecular Genetics, Russian Academy of Sciences
- Edição: Volume 45, Nº 6 (2018)
- Páginas: 589-600
- Seção: Animal and Human Physiology
- URL: https://ogarev-online.ru/1062-3590/article/view/182816
- DOI: https://doi.org/10.1134/S1062359018060055
- ID: 182816
Citar
Resumo
In this review, based on published experimental and clinical data (1980‒2016), a comparative analysis of the structures and effects of Semax (peptide drug) and its analogue fragments was carried out. The effect of these oligopeptides on various body systems is examined. The multiple effects of Semax for a number of diseases have been collected for a single scheme of corrective processes. The rationale for the long-term therapeutic effects of this peptide drug is presented. A comparative analysis of the temporal dynamics of the expression of certain genes is carried out.
Sobre autores
S. Koroleva
Institute of Molecular Genetics, Russian Academy of Sciences
Autor responsável pela correspondência
Email: svr.koroleva@gmail.com
Rússia, Moscow, 123182
N. Myasoedov
Institute of Molecular Genetics, Russian Academy of Sciences
Email: svr.koroleva@gmail.com
Rússia, Moscow, 123182
Arquivos suplementares
